GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stemline Therapeutics Inc (NAS:STML) » Definitions » Accounts Receivable

Stemline Therapeutics (Stemline Therapeutics) Accounts Receivable : $11.88 Mil (As of Mar. 2020)


View and export this data going back to 2013. Start your Free Trial

What is Stemline Therapeutics Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Stemline Therapeutics's accounts receivables for the quarter that ended in Mar. 2020 was $11.88 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Stemline Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2020 was 122.17.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Stemline Therapeutics's Net-Net Working Capital per share for the quarter that ended in Mar. 2020 was $2.63.


Stemline Therapeutics Accounts Receivable Historical Data

The historical data trend for Stemline Therapeutics's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemline Therapeutics Accounts Receivable Chart

Stemline Therapeutics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 15.12

Stemline Therapeutics Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.62 15.09 16.57 15.12 11.88

Stemline Therapeutics Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Stemline Therapeutics Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Stemline Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2020 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=11.88/8.873*91
=122.17

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Stemline Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Stemline Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2020 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(151.524+0.75 * 11.88+0.5 * 1.389-22.964
-0-0)/52.5046
=2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Stemline Therapeutics Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Stemline Therapeutics's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemline Therapeutics (Stemline Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
750 Lexington Avenue, 11th Floor, New York, NY, USA, 10022
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. Its pipeline product candidates include felezonexor (SL-801, an XPO1 inhibitor), SL-1001 (a RET kinase inhibitor), SL-901 (a kinase inhibitor) and SL-701 (an immunotherapy). The company is also involved in advancing its clinical stage programs, expanding and strengthening its intellectual property portfolio, identifying and acquiring additional product and technology rights.
Executives
Darren S Cline director 35 CAMBRIDGE PARK DRIVE, CAMBRIDGE MA 02140
Kenneth J Zuerblis director 20 KINGSBRIDGE RD, PISCATAWAY NJ 08854
Daniel Hume director 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK NY 10019
Kenneth Hoberman officer: Chief Operating Officer 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10024
Ron Bentsur director 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022
Alan S Forman director 55 WHITNEY AVENUE, 5TH FLOOR, NEW HAVEN CT 06511
Eric Dobmeier director C/O SAETTLE GENETICS INC, 21823 30TH DRIVE SE, BOTHELL WA 98021
J Kevin Buchi director 41 MOORES ROAD, FRAZER PA 19355
Eric K Rowinsky officer: Chief Medical Officer IMCLONE SYSTEMS INCORPORATED, 180 VARICK STREET, 6TH FLOOR, NEW YORK NY 10014